291 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
be guaranteed and there is no assurance that the company will achieve its financial guidance and long-term targets, that the company’s future clinical
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
Based Targets (SBT) Published first Task Force on Climate Related Financial Disclosure (TCFD) Report Executed a second 15-year virtual power purchase
8-K
EX-99.1
krd 9sgc8
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
8-K
EX-99.1
5an pvpel
8 Jan 24
Regulation FD Disclosure
10:29am
SC TO-C
EX-99.4
p85 k78v4e7iq
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.2
lxq6eq2b nv2xovu6
26 Dec 23
Information about tender offer
4:22pm
DFAN14A
EX-99.1
gtlu62553u cm
22 Dec 23
Additional proxy materials by non-management
4:21pm
8-K
EX-99.1
ch8tihfhj6y8ouf
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
EX-99.1
nvdag72yi8un8pv9
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.2
kp2upb qop
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DFAN14A
9r6e862
10 Oct 23
Additional proxy materials by non-management
6:48am
8-K
EX-99.2
jc05e4
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
EX-99.1
7f2moqyjn9 757u5
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am